Chad Ray is an accomplished professional with extensive experience in the pharmaceutical industry, currently serving as Executive Director at Zoetis since April 2017, after previously holding the position of Senior Scientific Director. Prior roles include Senior Director and Associate Research Fellow at Pfizer from October 2014 to March 2017, and Senior Director at ICON plc from June 2013 to October 2014. Chad Ray has also served in various capacities at Pfizer, Radix BioSolutions, Amgen, and Eli Lilly, progressing from Scientist to Senior Scientist and ultimately to senior leadership roles. Chad Ray holds a Doctor of Philosophy (Ph.D.) in Pathology Laboratory Medicine from Indiana University Indianapolis, having completed the degree in 2006. Leading a team of analytical scientists, Chad Ray focuses on pharmacokinetics (PK) and pharmacodynamics (PD) measurements in preclinical settings.